Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: A prospective study among middle-aged and older Chinese

Diabetologia

Volumn 57, Issue 9, 2014, Pages 1834-1841

  Liu, Xin ^a   Lu, Ling ^a   Yao, Pang ^a   Ma, Yiwei ^a   Wang, Feijie ^a   Jin, Qianlu ^a   Ye, Xingwang ^a   Li, Huaixing ^a   Hu, Frank B ^b,c   Sun, Liang ^a   Lin, Xu ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Lipopolysaccharide binding protein; Metabolic syndrome; Obesity; Prospective cohort study

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FERRITIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPOLYSACCHARIDE BINDING PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PALMITOLEIC ACID; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; CARRIER PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AGE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; INCIDENCE; MIDDLE AGED;

ACUTE-PHASE PROTEINS; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; FEMALE; HUMANS; INCIDENCE; MALE; MEMBRANE GLYCOPROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES;

EID: 84905584978     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3288-7     Document Type: Article

References (30)

1. Zhao L (2013) The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 11:639-647
2. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328:228-231
3. Qin J, Li Y, Cai Z, et al. (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55-60
4. Kemp DM (2013) Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota? Adipocyte 2:188-190
5. Mehta NN, McGillicuddy FC, Anderson PD, et al. (2010) Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59:172-181
6. Novitsky TJ (1998) Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci 851:416-421
7. Schumann RR (2011) Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. Biochem Soc Trans 39:989-993
8. Ruiz AG, Casafont F, Crespo J, et al. (2007) Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 17:1374-1380
9. Sun L, Yu Z, Ye X, et al. (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33:1925-1932
10. Teixeira TF, Souza NC, Chiarello PG, et al. (2012) Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 31:735-740
11. Manco M, Putignani L, Bottazzo GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31:817-844
12. Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F (2013) Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 8:e54600
13. Moreno-Navarrete JM, Escote X, Ortega F, et al. (2013) A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia 56:2524-2537
14. Zong G, Zhu J, Sun L, et al. (2013) Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese. Am J Clin Nutr 98:319-326
15. Sun L, Zong G, Pan A, et al. (2013) Elevated plasma ferritin is associated with increased incidence of type 2 diabetes in middle-aged and elderly Chinese adults. J Nutr 143:1459-1465
16. Yu Z, Ye X, Wang J, et al. (2009) Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese people. Circulation 119:2969-2977
17. Zhou BF (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults - study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15:83-96
18. Grundy SM, Cleeman JI, Daniels SR, et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735-2752
19. Zou G (2004) A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159:702-706
20. Cani PD, Amar J, Iglesias MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761-1772
21. Bartolome N, Aspichueta P, Martinez MJ, et al. (2012) Biphasic adaptative responses in VLDL metabolism and lipoprotein homeostasis during Gram-negative endotoxemia. Innate Immun 18:89-99
22. Feingold KR, Staprans I, Memon RA, et al. (1992) Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33:1765-1776
23. Sugita H, Kaneki M, Tokunaga E, et al. (2002) Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282:E386-E394
24. Gornik I, Vujaklija A, Lukic E, Madzarac G, Gasparovic V (2010) Hyperglycemia in sepsis is a risk factor for development of type II diabetes. J Crit Care 25:263-269
25. Visschers RG, Olde Damink SW, Schreurs M, Winkens B, Soeters PB, van Gemert WG (2009) Development of hypertriglyceridemia in patients with enterocutaneous fistulas. Clin Nutr 28:313-317
26. Hudgins LC, Parker TS, Levine DM, et al. (2003) A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 44:1489-1498
27. Zong G, Ye X, Sun L, et al. (2012) Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese. Am J Clin Nutr 96:970-976
28. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911-919, quiz 920
29. Shah R, Hinkle CC, Haris L, Mehta NN, Putt ME, Reilly MP (2012) Adipose genes down-regulated during experimental endotoxemia are also suppressed in obesity. J Clin Endocrinol Metab 97:E2152-E2159
30. Pini M, Castellanos KJ, Rhodes DH, Fantuzzi G (2013) Obesity and IL-6 interact in modulating the response to endotoxemia in mice. Cytokine 61:71-77